Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
J&J Snack Foods
JJSF
$1.43B
| $1.12M | ﹤0.01% |
7,777
+1
| +0% | +$151 |
|
1577
Hayward Holdings
HAYW
$3.21B
| $1.12M | ﹤0.01% |
73,320
+2
| +0% | +$27 |
|
1578
CVB Financial
CVBF
$3.94B
| $1.12M | ﹤0.01% |
62,928
| – | – |
|
1579
Four Corners Property Trust
FCPT
$2.81B
| $1.12M | ﹤0.01% |
45,765
+1
| +0% | +$24 |
|
1580
Douglas Emmett
DEI
$1.98B
| $1.12M | ﹤0.01% |
80,424
+3
| +0% | +$41 |
|
1581
Aurora
AUR
$12.6B
| $1.11M | ﹤0.01% |
393,575
+122,630
| +45% | +$352K |
|
1582
LGI Homes
LGIH
$1.27B
| $1.11M | ﹤0.01% |
9,558
+1
| +0% | +$118 |
|
|
FLG
1583
Flagstar Bank National Association
FLG
$5.93B
| $1.11M | ﹤0.01% |
115,230
+2
| +0% | +$37 |
|
|
PDCO
1584
DELISTED
Patterson Companies, Inc.
PDCO
| $1.1M | ﹤0.01% |
39,974
-15
| -0% | -$427 |
|
1585
Bank of Hawaii
BOH
$3.15B
| $1.1M | ﹤0.01% |
17,702
-1
| -0% | -$63 |
|
1586
Vail Resorts
MTN
$5.32B
| $1.1M | ﹤0.01% |
4,916
-11,443
| -70% | -$2.54M |
|
1587
Hess Midstream
HESM
$5.24B
| $1.09M | ﹤0.01% |
30,283
+3
| +0% | +$101 |
|
|
EXAS
1588
DELISTED
Exact Sciences
EXAS
| $1.09M | ﹤0.01% |
15,828
+2
| +0% | +$127 |
|
1589
Liberty Live Group Series C
LLYVK
$9.07B
| $1.09M | ﹤0.01% |
24,934
+1
| +0% | +$38 |
|
1590
Teladoc Health
TDOC
$1.22B
| $1.09M | ﹤0.01% |
72,425
+1
| +0% | +$18 |
|
1591
News Corp Class A
NWSA
$14.9B
| $1.09M | ﹤0.01% |
41,693
-19
| -0% | -$482 |
|
1592
Minerals Technologies
MTX
$2.36B
| $1.09M | ﹤0.01% |
14,491
+1
| +0% | +$70 |
|
1593
Guardant Health
GH
$21.5B
| $1.09M | ﹤0.01% |
52,749
+20
| +0% | +$429 |
|
1594
Independent Bank
INDB
$3.99B
| $1.09M | ﹤0.01% |
20,906
+1
| +0% | +$55 |
|
1595
Celldex Therapeutics
CLDX
$2.99B
| $1.09M | ﹤0.01% |
25,922
+39
| +0.2% | +$1.6K |
|
1596
CAE Inc. Common Shares
CAE
$8.3B
| $1.08M | ﹤0.01% |
52,483
+2,900
| +6% | +$58.2K |
|
1597
W.P. Carey
WPC
$16.8B
| $1.08M | ﹤0.01% |
19,206
+4
| +0% | +$239 |
|
1598
Denali Therapeutics
DNLI
$3.65B
| $1.08M | ﹤0.01% |
52,718
+26
| +0% | +$489 |
|
1599
Sylvamo
SLVM
$1.49B
| $1.07M | ﹤0.01% |
17,405
+1
| +0% | +$53 |
|
1600
Dave & Buster's
PLAY
$377M
| $1.07M | ﹤0.01% |
17,116
-14
| -0.1% | -$803 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.